PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 11 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aqueous extract of aerial parts (20 mg/kg) demonstrated antihyperglycemic and antihyperlipidemic effects in streptozotocin-induced diabetic rats [PMID:32767952]
Aqueous extract of aerial parts was evaluated for antihypertensive activity in normotensive and hypertensive rats [PMID:31822260]
Methanolic ultrasound-assisted extract exhibited bactericidal effects, specifically inhibiting Proteus mirabilis [PMID:41503838]
Aqueous extract completely inhibits aflatoxin production by Aspergillus flavus without reducing fungal growth [PMID:28257049]
Ethanol extracts exhibited antioxidant activity comparable to alpha-tocopherol [PMID:12601688]
Evidence summary
PubMed sources
- 1.PMID: 32767952 (2021) — Antihyperglycemic Activity of Micromeria graeca Aqueous Extract in Streptozotocin-Induced Diabetic Rats. · Endocrine, metabolic & immune disorders drug targets
- 2.PMID: 31822260 (2020) — Cardiovascular Effects of Micromeria graeca (L.) Benth. ex Rchb in Normotensive and Hypertensive Rats. · Endocrine, metabolic & immune disorders drug targets
- 3.PMID: 40872215 (2025) — In Vitro Shoot Cultures of Micromeria graeca: Micropropagation and Evaluation of Methanolic Extracts for Anticancer and Antimicrobial Activity. · Plants (Basel, Switzerland)
- 4.PMID: 41503838 (2026) — Exploitation of the Antibacterial Activity of Micromeria graeca L. Extracts From Northern Morocco. · Chemistry & biodiversity
- 5.PMID: 15878246